pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • CHLORHEXIDINE GLUCONATE SOLUTION 0.75% ANTISEPTIC
    CHLORHEXIDINE GLUCONATE SOLUTION 0.75% ANTISEPTIC
    no indication BAJAJ
  • Phase 1
    CHM-0201
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Chimeric Therapeutics Ltd
  • Phase 2
    CHM-2101
    Colon Cancer Chimeric Therapeutics Ltd
  • Phase 2
← prev
page 69 of 231
next →
131
Pain89
Neurology1
CHOH-01
B-Cell Non-Hodgkin Lymphoma
CHO Pharma Inc
  • CHOLESTYRAMINE POWDER FOR SUSPENSION
    CHOLESTYRAMINE POWDER FOR SUSPENSION
    no indication ALKEM LABS LTD
  • CHOLETEC
    CHOLETEC (MEBROFENIN)
    no indication BRACCO
  • CHROMIUM
    CHROMIUM (CHROMIC CHLORIDE)
    no indication HOSPIRA
  • Preclinical
    CHT-103
    Hematological Tumor Nanjing Miracle Biotechnology Co Ltd
  • Preclinical
    CHT-104
    Hematological Tumor Nanjing Miracle Biotechnology Co Ltd
  • Preclinical
    CHT-105
    Autoimmune Disorders Nanjing Miracle Biotechnology Co Ltd
  • Preclinical
    CIB-201
    Renal Cell Carcinoma Cellinfinity Bio Inc
  • Preclinical
    CIC-39
    Duchenne Muscular Dystrophy ChemIcare Srl
  • Phase 1
    CID-078
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Circle Pharma Inc
  • Phase 2
    CID-103
    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytope…$CASIF CASI Pharmaceuticals, Inc.
  • Preclinical
    CIL-05
    Primary Ciliary Dyskinesia Cila Therapeutics Inc
  • Phase 1
    CIN-110
    Obesity CinFina Pharma LLC
  • CINACALCET
    CINACALCET
    no indication Aurobindo Pharma Ltd
  • Preclinical
    CIRC-825
    Batten Disease Circumvent Pharmaceuticals Inc
  • CITANEST FORTE DENTAL
    CITANEST FORTE DENTAL (PRILOCAINE HCL AND EPINEPHRINE)
    no indication Septodont Inc
  • Phase 1
    CK-0801
    Myelodysplastic Syndrome (Preleukemia) Cellenkos Inc
  • Phase 1
    CK-0802
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Cellenkos Inc
  • Phase 1
    CK-0803
    Amyotrophic Lateral Sclerosis Cellenkos Inc
  • Preclinical
    CKD Program
    Diabetic Nephropathy Arch Biopartners Inc
  • Phase 1
    CKD-508
    Dyslipidemia Archela Inc
  • Preclinical
    CL-04177
    Hematological Tumor Cleara Biotech BV
  • Preclinical
    CL-04183
    Metastatic Colorectal Cancer Cleara Biotech BV
  • CLARINEX-D 12 HOUR
    CLARINEX-D 12 HOUR (DESLORATADINE AND PSEUDOEPHEDRINE SULFATE)
    no indication ORGANON LLC
  • CLARITIN-D 24 HOUR
    CLARITIN-D 24 HOUR (LORATADINE PSEUDOEPHEDRINE SULFATE)
    no indication P AND L
  • Phase 1
    CLBR-001
    B-Cell Chronic Lymphocytic Leukemia California Institute for Biomedical Research
  • Preclinical
    CLD-001
    Unspecified Hematological Disorders Celaid Therapeutics Inc